A.-M. Stoppa

1.4k citations

22 papers · 970 indexed · h-index 14

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Oncology top 5%
- Viral-associated cancers and disorders
- Polyomavirus and related diseases

Papers in

Hematology 13
- Hematopoietic Stem Cell Transplantation 8
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 5
Oncology 12
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 3

Co-authors: Didier Blaise Mohamad Mohty Catherine Faucher Norbert Vey D Maraninchi J.A. Gastaut Nöel Milpied Pierre Quartier
Journals: Bone Marrow Transplantation (4 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Transplant International (2 papers)Leukemia (2 papers)
Partner nations: France United Kingdom Sweden

In The Last Decade

A.-M. Stoppa

22 papers receiving 939 citations

Peers

Countries citing papers authored by A.-M. Stoppa

Since Specialization

Citations

This map shows the geographic impact of A.-M. Stoppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-M. Stoppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-M. Stoppa more than expected).

Fields of papers citing papers by A.-M. Stoppa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-M. Stoppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-M. Stoppa. The network helps show where A.-M. Stoppa may publish in the future.

Co-authors

The 25 scholars most cited alongside A.-M. Stoppa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.-M. Stoppa Line = papers co-authored together A.-M. Stoppa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study Annals of Hematology ·Margaret Macro, Cyrille Hulin, Laure Vincent, Dong-Hong Wu, Lotfi Benboubker, 李博宇, A.-M. Stoppa, Kamel Laribi, José Horacio Rivera Posada, Sevınç Şahbaz, Tammo J. Huppertz, Valentine Richez, F. Maloisel, Lionel Karlin, X. S. Lozano, C. Chouaïd, Xavier Leleu	2023	6
2	B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK HemaSphere ·Murielle Roussel, Oscar Orlando Blanco Beltrán, Susi Lastianingsih, A.J. Noble, R. N. MATHUR, Bruno Royer, Stéphanie Harel, Éstelle Desport, 恵忠平, M. Niault, Lionel Karlin, O. Decaux, Thomas Chalopin, Benjamin Carpentier, Margaret Macro, M.R. Vignon, Émilie Chalayer, A.-M. Stoppa, Frank Bridoux, Arnaud Jaccard	2023	4
3	Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial Leukemia ·Nizar J. Bahlis, Alessandro Corso, Fatma Betül Öz, Tereza Suyane Alves de França, P. Desjardins, A.-M. Stoppa, O. Decaux, Thierry de Revel, Miquel Granell, Gérald Marit, Hareth Nahi, H Demuynck, Shang‐Yi Huang, Supratik Basu, Troy H. Guthrie, Annette Ervin‐Haynes, J Marek, 内賀嶋英明, Thierry Façon	2017	14
4	Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial Clinical Lymphoma Myeloma & Leukemia ·Nizar J. Bahlis, Alessandro Corso, Lars‐Olof Mügge, Zhixiang Shen, P. Desjardins, A.-M. Stoppa, O. Decaux, Thierry de Revel, Miquel Granell, Gérald Marit, Hareth Nahi, H Demuynck, Shang‐Yi Huang, Supratik Basu, Annette Ervin‐Haynes, Nicolas Leupin, J Marek, 内賀嶋英明, Thierry Façon	2015	2
5	Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years Bone Marrow Transplantation ·Holger W. Auner, Richard Szydlo, Jennifer Hoek, Hartmut Goldschmidt, A.-M. Stoppa, Gareth J. Morgan, Philippe Moreau, Michel Attal, Gérald Marit, Nigel H. Russell, Mats Brune, Gordon Cook, Pieter Sonneveld, Stefan Schönland, Laurent Garderet, Nicolaus Kröger	2014	72
6	Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs Bone Marrow Transplantation ·Catherine Faucher, Anne‐Gaëlle Le Corroller, Benjamin Esterni, Norbert Vey, A.-M. Stoppa, Christian Chabannon, Mohamad Mohty, Mauricette Michallet, Jacques Olivier Bay, Dominique Genre, D Maraninchi, Patrice Viens, J. P. Moatti, Didier Blaise	2011	35
7	Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT Bone Marrow Transplantation ·Luca Castagna, S. Fürst, Arismel Tena Meza, Jean El Cheikh, Catherine Faucher, Mohamad Mohty, Réda Bouabdallah, Norbert Vey, A.-M. Stoppa, Benjamin Esterni, Didier Blaise	2010	34
8	Prise en charge actuelle de la leucémie lymphoïde chronique La Revue de Médecine Interne ·Thérèse Aurran‐Schleinitz, Christine Arnoulet, Ivanov Vv, Diane Coso, Jérôme Rey, Antonio Scorza, A.-M. Stoppa, Réda Bouabdallah, J.A. Gastaut	2007	2
9	The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison Leukemia ·Mohamad Mohty, Hugues de Lavallade, Patrick Ladaique, Catherine Faucher, Norbert Vey, Diane Coso, A.-M. Stoppa, J. A. Gastaut, Didier Blaise	2005	79
10	The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison Biology of Blood and Marrow Transplantation ·Hugues de Lavallade, Mohamad Mohty, Catherine Faucher, Norbert Vey, Diane Coso, A.-M. Stoppa, J.A. Gastaut, Patrick Ladaique, Christian Chabannon, Didier Blaise	2005	1
11	Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation Bone Marrow Transplantation ·Mohamad Mohty, J.-M. Boiron, Назерке Тулєсова, Anne‐Sophie Michallet, Jacques‐Olivier Bay, Catherine Faucher, Mark Neubauer, Karin Bilger, Diane Coso, A.-M. Stoppa, Reza Tabrizi, J.A. Gastaut, Mauricette Michallet, D Maraninchi, Didier Blaise	2004	57
12	Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center European Journal Of Haematology ·Назерке Тулєсова, Mohamad Mohty, Norbert Vey, Evelyne D’Incan, Réda Bouabdallah, Catherine Faucher, A.-M. Stoppa, J.A. Gastaut	2004	101
13	Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin’s lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutive ISC trials Annals of Oncology ·Réda Bouabdallah, A.-M. Stoppa, Diane Coso, V J Bardou, Didier Blaise, Christian Chabannon, J A Gastaut, D Maraninchi	2001	6
14	Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation British Journal of Cancer ·Luc Xerri, Réda Bouabdallah, Élisabeth Devilard, J Hassoun, A.-M. Stoppa, F Birg	1998	29
15	Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center Annals of Oncology ·V Morfino, Luc Xerri, V J Bardou, A.-M. Stoppa, Didier Blaise, D Sainty, D Maraninchi, J A Gastaut	1998	42
16	Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma. Journal of Clinical Oncology ·A.-M. Stoppa, Réda Bouabdallah, Christian Chabannon, G Novakovitch, Norbert Vey, Jacques Camerlo, Didier Blaise, Luc Xerri, M. Resbeut, Giulia Di Stefano, V J Bardou, J A Gastaut, D Maraninchi	1997	37
17	Interleukin-2 in Association with Increasing Doses of Interferon-Gamma in Patients with Advanced Cancer Journal of Immunotherapy ·Patrice Viens, Didier Blaise, A.-M. Stoppa, M. Brandely, D Baume, D Olive, M. Resbeut, Jean‐Robert Delpéro, 고의경, Carole E. Aubert, Y Aymé, Daniel Hans, C Bressac, J. B. Hatcher, D Maraninchi	1992	3
18	Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III?IV acute graft-versus-host disease Transplant International ·A.-M. Stoppa, D Maraninchi, Didier Blaise, Patrice Viens, M. Hirn, Daniel Olive, Josy Reiffers, Nöel Milpied, M Gaspard, Claude Mawas	1991	24
19	Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease Transplant International ·A.-M. Stoppa, D Maraninchi, Didier Blaise, Patrice Viens, A. Kim, Daniel Olive, Josy Reiffers, Nöel Milpied, M Gaspard, Claude Mawas	1991	11
20	Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial British Journal of Haematology ·Josy Reiffers, M Gaspard, D Maraninchi, Mauricette Michallet, Gérald Marit, A.-M. Stoppa, Bernadette Corront, B. David, J.A. Gastaut, 巣黒慎太郎, A Broustet, Y Carcassonne, D Hollard	1989	93

About A.-M. Stoppa

A.-M. Stoppa is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 22 papers that have together received 970 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (7 papers), Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (537 citations), Oncology (484 citations), Pathology and Forensic Medicine (240 citations), Transplantation (36 citations) and Genetics (130 citations). A.-M. Stoppa has collaborated with scholars based in France, United Kingdom and Sweden. Frequent co-authors include Didier Blaise, Mohamad Mohty, Catherine Faucher, Norbert Vey, D Maraninchi, J.A. Gastaut, Nöel Milpied, Pierre Quartier, Bruno Hurault de Ligny and Yves Réguerre. Their work appears in journals such as Bone Marrow Transplantation, Annals of Oncology, Journal of Clinical Oncology, Transplant International and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact